These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38518034)

  • 1. Comprehensive pan-cancer analysis of 33 human cancers reveals immunotherapeutic value of focal adhesion tyrosine kinase.
    Shi Y; Ju M; Zhang Y; Liang L; Sun X; Di X
    Medicine (Baltimore); 2024 Mar; 103(12):e37362. PubMed ID: 38518034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
    Mo Z; Li P; Cao Z; Zhang S
    Front Immunol; 2021; 12():564948. PubMed ID: 34290693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
    Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
    Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis.
    Zhao Z; Yang Y; Liu Z; Chen H; Guan X; Jiang Z; Yang M; Liu H; Chen T; Gao Y; Zou S; Wang X
    Front Mol Biosci; 2022; 9():951636. PubMed ID: 36188226
    [No Abstract]   [Full Text] [Related]  

  • 7. PTK2-associated gene signature could predict the prognosis of IPF.
    Feng A; Caro YM; Gardner C; Grischo G; Liang Y; Wickremasinghe PD; Polmann M; Kala M; Marlowe T; Black SM; Knox KS; Wang T
    Respir Res; 2023 Dec; 24(1):304. PubMed ID: 38053045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapeutic Value of Transcription Factor 19 (TCF19) Associated with Renal Clear Cell Carcinoma: A Comprehensive Analysis of 33 Human Cancer Cases.
    Cheng X; Hou J; Wen X; Dong R; Lu Z; Jiang Y; Wu G; Yuan Y
    J Oncol; 2022; 2022():1488165. PubMed ID: 36111242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
    Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
    Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis.
    Ye Y; Jiang H; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Mol Biosci; 2022; 9():1001225. PubMed ID: 36213111
    [No Abstract]   [Full Text] [Related]  

  • 11. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
    Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
    Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types.
    Liu T; Zhang J; Lin C; Liu G; Xie G; Dai Z; Yu P; Wang J; Guo L
    Front Cell Dev Biol; 2022; 10():839136. PubMed ID: 35372330
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy.
    He S; Yu J; Sun W; Sun Y; Tang M; Meng B; Liu Y; Li J
    Front Genet; 2022; 13():969476. PubMed ID: 36186454
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
    Han X; Ye J; Huang R; Li Y; Liu J; Meng T; Song D
    Front Immunol; 2022; 13():900273. PubMed ID: 36159856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis-related gene HIC1 in the prediction of the prognosis and immunotherapeutic efficacy with immunological activity.
    Wu Y; Lin Z; Tang X; Tong Z; Ji Y; Xu Y; Zhou Z; Yang J; Li Z; Liu T
    Front Immunol; 2023; 14():1182030. PubMed ID: 37388742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers.
    Wu G; Dong Y; Hu Q; Ma H; Xu Q; Xu K; Chen H; Yang Z; He M
    Cell Cycle; 2023 Sep; 22(18):1969-1985. PubMed ID: 37811868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
    Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
    Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.
    Schlaepfer DD; Ojalill M; Stupack DG
    J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 39034922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
    Anaganti S; Fernández-Cuesta L; Langerød A; Hainaut P; Olivier M
    Cancer Lett; 2011 Jan; 300(2):215-24. PubMed ID: 21071137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.